United States National Library of Medicine National Institutes of Health

2009AA MedDRA Source Information

Counts

 (skip to: notes  samples)

Attribute Name Description Count (MRSAT.RRF)
SMQ_TERM_ADDVERSION Standardised MedDRA Query (SMQ) Addition Version. Version of MedDRA in which term was added to the SMQ. 96378
SMQ_TERM_CAT Standardised MedDRA Query (SMQ) Term Category. A single alphabetical letter indicating the category of the term for application of the SMQ algorithm. If the SMQ does not use algorithms, then all Term_category values are assigned "A." For a child SMQ, this field is assigned "S." 96378
SMQ_TERM_LMVERSION Standardised MedDRA Query (SMQ) Last Modified Version. Version of MedDRA in which term was last modified in the SMQ. 96378
SMQ_TERM_SCOPE Standardised MedDRA Query (SMQ) Term Scope. Defines the MedDRA term as a member of the broad scope (1), narrow scope (2) of the SMQ search, or a child SMQ (0) (zero). 96378
SMQ_TERM_STATUS Standardised MedDRA Query (SMQ) Term Status. Identifies a term as active ("A") or inactive ("I") within this SMQ. 96378
SMQ_TERM_WEIGHT Standardised MedDRA Query (SMQ) Term Weight. Used for some SMQ algorithms; "0" is used as default. 96378
MXR MedDRA cross reference to COSTART, HARTS, ICD9, ICD-9-CM, J-ART or WHOART 41678
SMQ_TERM_LEVEL Standardised MedDRA Query (SMQ) Term Level. The MedDRA hierarchy level of a term (4=PT, 5=LLT) or 0 (zero) for a child SMQ. 34269
MPS MedDRA primary SOC (PTs may have multiple treepositions, but each has a primary soc) 18209
SMQ_ALGO Standardised MedDRA Query (SMQ) Algorithm. Boolean expression of algorithm for the SMQ. "N" if the SMQ does not utilize an algorithm. 151
SMQ_LEVEL Standardised MedDRA Query (SMQ) Level. Value between 1 and 5 identifying the level of the SMQ within the hierarchy of SMQs; 1 is the most general, 5 is the most narrow. 151
SMQ_STATUS Standardised MedDRA Query (SMQ) Status. "A" = active; "I" = inactive. 151
SMQ_SOURCE Standardised MedDRA Query (SMQ) Source. Source for the development of the SMQ, e.g. medical references. 116
SOS Scope Statement 78
MISO MedDRA Serial Code International SOC Sort Order Digit (01-26) 26
FROMRSAB Root source abbreviation for the "from" identifiers of a map set 2
FROMVSAB Versioned source abbreviation for the "from" identifiers of a map set 2
MAPSETRSAB Root source abbreviation for a map set 2
MAPSETTYPE Indicates the nature of a map set. Its value is map set specific. It can be used to indicate the inclusion of one to one, one to many and choices of maps. 2
MAPSETVERSION Version of the map set 2
MAPSETVSAB Versioned source abbreviation for a map set 2
MTH_MAPFROMCOMPLEXITY Indicates the complexity of "from" expressions used in a map set 2
MTH_MAPFROMEXHAUSTIVE Indicates whether or not the "from" source of a map set is completely mapped 2
MTH_MAPSETCOMPLEXITY Indicates the overall complexity of a map set 2
MTH_MAPTOCOMPLEXITY Indicates the complexity of "to" expressions in a map set 2
MTH_MAPTOEXHAUSTIVE Indicates whether or not the "to" source is completely mapped 2
TORSAB Root source abbreviation for the "to" identifiers of a map set 2
TOVSAB Versioned source abbreviation for the "to" identifiers of a map set 2

Notes

  • Attributes included every discrete piece of information about a concept, an atom, or a relationship that is not part of the basic Metathesaurus concept structure or distributed in one of the relationship files.
  • Attribute Names (ATN) are based on source documentation or NLMs understanding of the source.
  • Sample attribute values (ATV) are provided for each ATN in the source.
  • Sample data highlight examples of ATNs and Attribute Values (ATV) in MRSAT.RRF.
  • See Appendix B.2 for a complete list of attribute names.
  • See UMLS Documentation Section 2.7.1.3.5 for more information on MRSAT.RRF.

Sample Data

SMQ_TERM_ADDVERSION

  (return to top)
CUI METAUI STYPE ATN ATV STR
C0018802 R92073458 RUI SMQ_TERM_ADDVERSION 10.0 Heart failure, congestive
C1869016 R92106374 RUI SMQ_TERM_ADDVERSION 8.0 Liver neoplasms, benign (SMQ)
C0156193 R92083400 RUI SMQ_TERM_ADDVERSION 8.0 Other sequelae of chronic liver disease
C0855395 R92066300 RUI SMQ_TERM_ADDVERSION 8.0 Coagulation factor IX level low
C0542063 R92076189 RUI SMQ_TERM_ADDVERSION 8.0 Jaundice hemologous serum-like
C1869021 R92106971 RUI SMQ_TERM_ADDVERSION 8.0 Events specifically reported as alcohol-related (SMQ)
C0857584 R92068764 RUI SMQ_TERM_ADDVERSION 8.0 Direct Coombs test abnormal
C0158967 R92076757 RUI SMQ_TERM_ADDVERSION 10.0 Late anemia due to isoimmunization of fetus or newborn
C1869024 R92107245 RUI SMQ_TERM_ADDVERSION 8.0 Severe cutaneous adverse reactions (SMQ)

SMQ_TERM_CAT

  (return to top)
CUI METAUI STYPE ATN ATV STR
C0858060 R92088555 RUI SMQ_TERM_CAT A Serum creatine phosphokinase abnormal
C0700225 R92088565 RUI SMQ_TERM_CAT A Serum creatinine increased
C1869012 R92105876 RUI SMQ_TERM_CAT A Liver related investigations, signs and symptoms (SMQ)
C1869017 R92106429 RUI SMQ_TERM_CAT A Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ)
C0023911 R92077325 RUI SMQ_TERM_CAT A Liver transplant
C0858200 R92061432 RUI SMQ_TERM_CAT A Anemia hemolytic indirect Coombs positive
C0241128 R92081155 RUI SMQ_TERM_CAT A Nikolsky's sign
C0239340 R92081700 RUI SMQ_TERM_CAT A Oedema lower limb
C0858619 R92097801 RUI SMQ_TERM_CAT A Corneal edema postoperative

SMQ_TERM_LMVERSION

  (return to top)
CUI METAUI STYPE ATN ATV STR
C1869007 R92105043 RUI SMQ_TERM_LMVERSION 7.1 Rhabdomyolysis/myopathy (SMQ)
C0855406 R92101519 RUI SMQ_TERM_LMVERSION 8.0 Coagulation factor VII level abnormal
C1869023 R92107152 RUI SMQ_TERM_LMVERSION 8.0 Haemolytic disorders (SMQ)
C0011606 R92068362 RUI SMQ_TERM_LMVERSION 8.0 Dermatitis exfoliative NOS
C1869024 R92107428 RUI SMQ_TERM_LMVERSION 8.0 Severe cutaneous adverse reactions (SMQ)
C1869038 R92107598 RUI SMQ_TERM_LMVERSION 8.1 Anaphylactic reaction (SMQ)
C0234940 R92075330 RUI SMQ_TERM_LMVERSION 8.1 Inflammatory edema reaction
C1869025 R92108381 RUI SMQ_TERM_LMVERSION 10.1 Acute pancreatitis (SMQ)
C1869027 R92109304 RUI SMQ_TERM_LMVERSION 8.1 Angioedema (SMQ)

SMQ_TERM_SCOPE

  (return to top)
CUI METAUI STYPE ATN ATV STR
C0232197 R92064719 RUI SMQ_TERM_SCOPE 1 Cardiac fibrillation NOS
C1869007 R92105125 RUI SMQ_TERM_SCOPE 1 Rhabdomyolysis/myopathy (SMQ)
C1869008 R92105324 RUI SMQ_TERM_SCOPE 1 Acute renal failure (SMQ)
C1869012 R92105968 RUI SMQ_TERM_SCOPE 1 Liver related investigations, signs and symptoms (SMQ)
C1869023 R92107064 RUI SMQ_TERM_SCOPE 2 Haemolytic disorders (SMQ)
C0580380 R92087829 RUI SMQ_TERM_SCOPE 1 Reticulocyte count abnormal NOS
C1869038 R92107532 RUI SMQ_TERM_SCOPE 1 Anaphylactic reaction (SMQ)
C1869038 R92107757 RUI SMQ_TERM_SCOPE 1 Anaphylactic reaction (SMQ)
C0542571 R92081681 RUI SMQ_TERM_SCOPE 1 Oedema face

SMQ_TERM_STATUS

  (return to top)
CUI METAUI STYPE ATN ATV STR
C0587246 R92093474 RUI SMQ_TERM_STATUS A Weakness of limbs
C0858054 R92085221 RUI SMQ_TERM_STATUS A Plasma cholinesterase decreased
C0854794 R92078032 RUI SMQ_TERM_STATUS A Malignant liver tumour recurrent
C1869019 R92106745 RUI SMQ_TERM_STATUS A Possible liver-related coagulation and bleeding disturbances (SMQ)
C0019159 R92073807 RUI SMQ_TERM_STATUS A Hep A
C0020649 R92063466 RUI SMQ_TERM_STATUS A Blood pressure drop arterial
C0033774 R92076136 RUI SMQ_TERM_STATUS A Itching
C0151602 R92086706 RUI SMQ_TERM_STATUS A Puffiness face
C1869026 R92108541 RUI SMQ_TERM_STATUS A Agranulocytosis (SMQ)

SMQ_TERM_WEIGHT

  (return to top)
CUI METAUI STYPE ATN ATV STR
C1869008 R92105371 RUI SMQ_TERM_WEIGHT 0 Acute renal failure (SMQ)
C0541781 R92061906 RUI SMQ_TERM_WEIGHT 0 Arms swollen red hot
C0239819 R92094973 RUI SMQ_TERM_WEIGHT 0 Edema hands
C1869015 R92106264 RUI SMQ_TERM_WEIGHT 0 Liver neoplasms, malignant and unspecified (SMQ)
C1869023 R92107078 RUI SMQ_TERM_WEIGHT 0 Haemolytic disorders (SMQ)
C0160887 R92063290 RUI SMQ_TERM_WEIGHT 0 Blister of hip, thigh, leg, and ankle, without mention of infection
C1869038 R92107659 RUI SMQ_TERM_WEIGHT 0 Anaphylactic reaction (SMQ)
C0002994 R92086991 RUI SMQ_TERM_WEIGHT 0 Quincke's edema
C0002874 R92061850 RUI SMQ_TERM_WEIGHT 0 Aplastic anemia

MXR

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0151888 A0422403 L0307340 S0378733 AUI 10021089 MXR J-ART: 0757 Hyporeflexia
C0021177 A1603178 L0021177 S1642075 AUI 10024421 MXR COSTART: LIBIDO INC Libido increased
C0234934 A1114670 L0318955 S1056656 AUI 10046755 MXR WHOART: 0044003 Urticaria vesiculosa
C0600097 A0793925 L0317645 S0733738 AUI 10039897 MXR HARTS: 4597 Sedation
C0034212 A0108168 L0034212 S0078946 AUI 10037632 MXR J-ART: 073004 Pyoderma
C0012002 A0048196 L0012002 S0032532 AUI 10012762 MXR ICD9CM: 93.34 Diathermy
C0035934 A0453977 L0035934 S0400982 AUI 10039281 MXR WHOART: 0694003 Rubinstein-Taybi syndrome
C0155626 A0275911 L0182490 S0247070 AUI 10000891 MXR ICD9: 410 Acute myocardial infarction
C0027059 A2849442 L0027059 S0064653 AUI 10028606 MXR COSTART: MYOCARDITIS Myocarditis

SMQ_TERM_LEVEL

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0022672 A0242649 L0001354 S0218507 CODE 10001049 SMQ_TERM_LEVEL 5 Acute renal failure with lesion of tubular necrosis
C0241039 A8254646 L1382249 S1643356 CODE 10033412 SMQ_TERM_LEVEL 5 Pain in (l) shoulder
C0858447 A1575047 L1367047 S1618073 CODE 10035459 SMQ_TERM_LEVEL 5 Plasma urea abnormal
C0520861 A1603153 L0856736 S1642055 CODE 10047240 SMQ_TERM_LEVEL 4 Venous pressure jugular increased
C0086565 A1595788 L1378121 S1635701 CODE 10019674 SMQ_TERM_LEVEL 5 Hepatic function disorder
C0013404 A1586433 L0287745 S1627568 CODE 10006338 SMQ_TERM_LEVEL 5 Breathing difficult
C0231848 A1578043 L0278900 S1620475 CODE 10020468 SMQ_TERM_LEVEL 5 Hunger air
C0162285 A0879539 L0749209 S0819939 CODE 10049850 SMQ_TERM_LEVEL 5 Blepharoedema
C0857092 A1596810 L1378503 S1636611 CODE 10013860 SMQ_TERM_LEVEL 5 Duodenal ulcer-type symptoms

MPS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0003708 A0026063 L0003708 S0015566 SDUI 10003074 MPS 10029205 Arachnoiditis
C0006444 A0033373 L0006444 S0021064 SDUI 10006811 MPS 10028395 Bursitis
C0262918 A1598543 L0300438 S1638158 SDUI 10015829 MPS 10015919 Extraocular muscle paresis
C0015672 A0058330 L0015672 S0040757 SDUI 10016256 MPS 10018065 Fatigue
C0020428 A0070579 L0020428 S0050324 SDUI 10020571 MPS 10014698 Hyperaldosteronism
C0023501 A0731385 L0023501 S0676134 SDUI 10024328 MPS 10005329 Leukaemoid reaction
C0852654 A1572941 L1365905 S1616476 SDUI 10000021 MPS 10010331 21-hydroxylase deficiency
C1262481 A1597778 L0299378 S1637445 SDUI 10017902 MPS 10017947 Gastroenteritis eosinophilic
C0037995 A0118725 L0037995 S0087599 SDUI 10041642 MPS 10042613 Splenectomy

SMQ_ALGO

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SMQ_ALGO N Rhabdomyolysis/myopathy (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SMQ_ALGO N Cardiac failure (SMQ)
C1869010 A12057517 L6511484 S7585620 SDUI 20000006 SMQ_ALGO N Possible drug related hepatic disorders - comprehensive search (SMQ)
C1869012 A12057868 L6511726 S7585510 SDUI 20000008 SMQ_ALGO N Liver related investigations, signs and symptoms (SMQ)
C1869013 A12056802 L6511443 S7585261 SDUI 20000009 SMQ_ALGO N Cholestasis and jaundice of hepatic origin (SMQ)
C1869014 A12057518 L6511652 S7585428 SDUI 20000010 SMQ_ALGO N Hepatitis, non-infectious (SMQ)
C1869015 A12056621 L6511665 S7585509 SDUI 20000011 SMQ_ALGO N Liver neoplasms, malignant and unspecified (SMQ)
C1869017 A12057343 L6511463 S7585427 SDUI 20000013 SMQ_ALGO N Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ)
C1869018 A12057698 L6511446 S7585282 SDUI 20000014 SMQ_ALGO N Congenital, familial, neonatal and genetic disorders of the liver (SMQ)

SMQ_LEVEL

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869006 A12057156 L6511616 S7585752 SDUI 20000001 SMQ_LEVEL 1 Torsade de pointes/QT prolongation (SMQ)
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SMQ_LEVEL 1 Rhabdomyolysis/myopathy (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SMQ_LEVEL 1 Cardiac failure (SMQ)
C1869009 A12057733 L6511462 S7585426 SDUI 20000005 SMQ_LEVEL 1 Hepatic disorders (SMQ)
C1869011 A12056801 L6511901 S7585621 SDUI 20000007 SMQ_LEVEL 3 Possible drug related hepatic disorders - severe events only (SMQ)
C1869012 A12057868 L6511726 S7585510 SDUI 20000008 SMQ_LEVEL 3 Liver related investigations, signs and symptoms (SMQ)
C1869013 A12056802 L6511443 S7585261 SDUI 20000009 SMQ_LEVEL 3 Cholestasis and jaundice of hepatic origin (SMQ)
C1869014 A12057518 L6511652 S7585428 SDUI 20000010 SMQ_LEVEL 4 Hepatitis, non-infectious (SMQ)
C1869015 A12056621 L6511665 S7585509 SDUI 20000011 SMQ_LEVEL 4 Liver neoplasms, malignant and unspecified (SMQ)

SMQ_STATUS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869006 A12057156 L6511616 S7585752 SDUI 20000001 SMQ_STATUS A Torsade de pointes/QT prolongation (SMQ)
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SMQ_STATUS A Rhabdomyolysis/myopathy (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SMQ_STATUS A Cardiac failure (SMQ)
C1869009 A12057733 L6511462 S7585426 SDUI 20000005 SMQ_STATUS A Hepatic disorders (SMQ)
C1869011 A12056801 L6511901 S7585621 SDUI 20000007 SMQ_STATUS A Possible drug related hepatic disorders - severe events only (SMQ)
C1869013 A12056802 L6511443 S7585261 SDUI 20000009 SMQ_STATUS A Cholestasis and jaundice of hepatic origin (SMQ)
C1869016 A12057869 L6511664 S7585508 SDUI 20000012 SMQ_STATUS A Liver neoplasms, benign (SMQ)
C1869017 A12057343 L6511463 S7585427 SDUI 20000013 SMQ_STATUS A Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (SMQ)
C1869018 A12057698 L6511446 S7585282 SDUI 20000014 SMQ_STATUS A Congenital, familial, neonatal and genetic disorders of the liver (SMQ)

SMQ_SOURCE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869006 A12057156 L6511616 S7585752 SDUI 20000001 SMQ_SOURCE Zipes DP. Specific arrhythmias: diagnosis and treatment. Heart Disease: A Textbook of Cardiovascular Medicine (5th Ed). Braunwald E (Ed). WB Saunders: Philadelphia, 1997, pg. 640-704. Marriott HJL and Conover MB. Polymorphic ventricular tachycardia. Advanced Concepts in Arrhythmias (3rd Ed). Mosby: New York, 1998, pg. 293-310. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders. Pharmacoepidemiology and Drug Safety 1998; 7:351-357. Torsade de pointes. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pg. 81-82 Josephson ME and Zimetbaum P. The tachyarrhythmias. Harrison's Principles of Internal Medicine (15th Ed). Braunwald E, Fauci AS, Kasper DL et al (Eds). McGraw-Hill: New York, 2001, pg. 1292-1309. Bauman JL and Schoen MD. Arrhythmias. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, 2002, pg. 273-303. Torsade de pointes/QT prolongation (SMQ)
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SMQ_SOURCE Basic requirements for the use of terms for reporting adverse drug reactions (IV). Pharmacoepidemiology and Drug Safety 1993; 2:149-153. Myopathy. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pg. 16-17. Poels PJE and Gabreels FJM. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg 1993; 95:175-192. Omar MA, Wilson JP, and Cox, TS. Rhabdomyolysis and HMG-CoA reductase inhibitors. Annals Pharmacother 2001; 35:1096-1107. Prendergast BD and George CF. Drug-induced rhabdomyolysis - mechanisms and management. Postgrad Med J 1993; 69:333-336. Rhabdomyolysis/myopathy (SMQ)
C1869008 A12056800 L6511448 S7585289 SDUI 20000003 SMQ_SOURCE The Merck Manual, 17th Edition Cecil Textbook of Medicine, 19th Edition Harrison's Principles of Internal Medicine, 13th Edition Acute renal failure (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SMQ_SOURCE Council for International Organisations of Medical Sciences (CIOMS). Reporting Adverse Drug Reactions. Definition of terms and criteria for their use. 1999: p 64-65 Cardiac failure (SMQ)
C1869024 A12057520 L6511492 S7585682 SDUI 20000020 SMQ_SOURCE Roujeau JC and Stern RS. Severe adverse cutaneous reactions to drugs. New England Journal of Medicine 1994; 331: 1272-1285. Reporting Adverse Drug Reactions. Definitions of terms and criteria for their use. CIOMS publication, Geneva 1999. Severe cutaneous adverse reactions (SMQ)
C1869038 A12057161 L6511588 S7585462 SDUI 20000021 SMQ_SOURCE 1 The Merck Manual. 15th edition. Merck, Sharp & Dohme Research Laboratories. (1987): 306-7 Anaphylactic reaction (SMQ)
C1869025 A12057005 L6511764 S7585273 SDUI 20000022 SMQ_SOURCE 1. Anonymous. Pancreatitis. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pp 53-54 2. Berardi RR and Montgomery PA. Pancreatitis. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, NY. 1999. pp 701-715 3. Greenberger NJ, Toskes PP, and Isselbacher KJ. Acute and chronic pancreatitis. Harrison's Principles of Internal Medicine (14th Ed). Fauci AS, Braunwald E, Isselbacher KJ et al (Eds). McGraw-Hill: New York, NY. 1998. pp 1741-1752 Acute pancreatitis (SMQ)
C1869026 A12056983 L6511876 S7585355 SDUI 20000023 SMQ_SOURCE 1. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Geneva, 1999 2. Harrison's Principles of Internal Medicine, 15th edition, Eugene Braunwald [et al.], McGraw-Hill, 2001 Agranulocytosis (SMQ)
C1869027 A12056622 L6511474 S7585499 SDUI 20000024 SMQ_SOURCE 1. Bankowski Z, Bruppacher R, Crusius I et al. Reporting adverse drug reactions, definition of terms and criteria for their use. Council for International Organizations of Medical Sciences (CIOMS) 1999 pp 12 -13 2. Dorland's Illustrated Medical Dictionary, 28th Edition 1994 p78 3. Braunwald E, Fauci A and Kasper D. Harrison's Principles of Internal Medicine, 15th Edition, 2001 p 341 and pp 1917-1918 4. Beers M and Berkow R. The Merck Manual of diagnosis and therapy, 17th edition, dated 1999 pp 1054-56 Angioedema (SMQ)

SOS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869006 A12057156 L6511616 S7585752 SDUI 20000001 SOS 1. Includes sudden and cardiac death terms as this is a frequent association with torsade de pointes. Torsade de pointes/QT prolongation (SMQ)
C1869007 A12057867 L6511681 S7585665 SDUI 20000002 SOS 1. Renal impairment/failure terms included because of the frequent association with rhabdomyolysis Rhabdomyolysis/myopathy (SMQ)
C1869091 A12057875 L6511505 S7585241 SDUI 20000004 SOS The CIOMS Working Group discussed in detail whether an algorithm could be applied to this SMQ based on the definition of cardiac failure provided. Such an algorithm, however, has not been tested by the CIOMS Working Group, therefore, the Working Group is requesting users to comment on the practical relevance of an algorithm approach. Such an algorithm could involve broad tersmsas follows: one oedema term, one dyspnoea term plus one clinical/sign/symptom or investigation making up 3 terms in total Cardiac failure (SMQ)
C1869038 A12057161 L6511588 S7585462 SDUI 20000021 SOS The following algorithm is used: All narrow search terms as well as: If one term from category B and one term from category C is present, or If one term from (category B or category C) plus one term from category D. Anaphylactic reaction (SMQ)
C1869025 A12057005 L6511764 S7585273 SDUI 20000022 SOS To apply algorithm - A report is considered a relevant case for further review if: 1) it includes a term from Category A (Narrow terms) OR 2) it includes at least one term from Category B (the list of laboratory values) and at least one term from Category C (the list of signs and symptoms) Acute pancreatitis (SMQ)
C1869026 A12056983 L6511876 S7585355 SDUI 20000023 SOS If possible, full blood counts and repeated white blood cell counts should be reported, sought for in follow up, and coded. Concerning database queries with broad search terms, additionally coded data on hematological values help to find relevant cases more easily. In case laboratory values are not coded in a database, individual review is then needed to decide upon relevance in the context of agranulocytosis. Agranulocytosis (SMQ)
C1869030 A12057521 L6511580 S7585405 SDUI 20000027 SOS Cases with no link to the category "Cytopenia and haematopoietic disorders affecting more than one type of blood cells" need to be reviewed for combinations of AEs/ADRs assigned to at least two of the other three SMQs to find all such cases. All types of potential combinations appear possible and need to be considered. Haematopoietic cytopenias (SMQ)
C1869031 A12056805 L6511767 S7585299 SDUI 20000028 SOS Cases with no link to the category "Cytopenia and haematopoietic disorders affecting more than one type of blood cells" need to be reviewed for combinations of AEs/ADRs assigned to at least two of the other three SMQs to find all such cases. All types of potential combinations appear possible and need to be considered. Cytopenia and haematopoietic disorders affecting more than one type of blood cell (SMQ)
C1869032 A12057344 L6511573 S7585354 SDUI 20000029 SOS Cases with no link to the category "Cytopenia and haematopoietic disorders affecting more than one type of blood cells" need to be reviewed for combinations of AEs/ADRs assigned to at least two of the other three SMQs to find all such cases. All types of potential combinations appear possible and need to be considered. Erythropenia (SMQ)

MISO

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1261322 A0976668 L0861064 S0919672 SDUI 10022891 MISO 23 Investigations
C0018799 A1588768 L0537218 S1629626 SDUI 10007541 MISO 11 Cardiac disorders
C0851352 A2016522 L1376503 S2162599 SDUI 10010331 MISO 21 Congenital, familial and genetic disorders
C0851353 A1585002 L1372278 S1626383 SDUI 10005329 MISO 03 Blood and lymphatic system disorders
C0027765 A1596081 L0297185 S1635977 SDUI 10029205 MISO 08 Nervous system disorders
C0015397 A1595746 L0012705 S1635657 SDUI 10015919 MISO 09 Eye disorders
C0851354 A1595679 L1378038 S1635566 SDUI 10013993 MISO 10 Ear and labyrinth disorders
C0851355 A1595973 L1378186 S1635875 SDUI 10038738 MISO 13 Respiratory, thoracic and mediastinal disorders
C0017178 A1595807 L0161543 S1635716 SDUI 10017947 MISO 14 Gastrointestinal disorders

FROMRSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 FROMRSAB MDR MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 FROMRSAB MDR MDR11_1 to CST95 Mappings

FROMVSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 FROMVSAB MDR11_1 MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 FROMVSAB MDR11_1 MDR11_1 to CST95 Mappings

MAPSETRSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 MAPSETRSAB MDR MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 MAPSETRSAB MDR MDR11_1 to CST95 Mappings

MAPSETTYPE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 MAPSETTYPE MedDRA to ICD9CM Mappings MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 MAPSETTYPE MedDRA to COSTART Mappings MDR11_1 to CST95 Mappings

MAPSETVERSION

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 MAPSETVERSION 200809 MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 MAPSETVERSION 200809 MDR11_1 to CST95 Mappings

MAPSETVSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 MAPSETVSAB MDR11_1 MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 MAPSETVSAB MDR11_1 MDR11_1 to CST95 Mappings

MTH_MAPFROMCOMPLEXITY

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 MTH_MAPFROMCOMPLEXITY SINGLE CODE MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 MTH_MAPFROMCOMPLEXITY SINGLE CODE MDR11_1 to CST95 Mappings

MTH_MAPFROMEXHAUSTIVE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 MTH_MAPFROMEXHAUSTIVE N MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 MTH_MAPFROMEXHAUSTIVE N MDR11_1 to CST95 Mappings

MTH_MAPSETCOMPLEXITY

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 MTH_MAPSETCOMPLEXITY ONE_TO_ONE MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 MTH_MAPSETCOMPLEXITY ONE_TO_ONE MDR11_1 to CST95 Mappings

MTH_MAPTOCOMPLEXITY

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 MTH_MAPTOCOMPLEXITY SINGLE CODE MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 MTH_MAPTOCOMPLEXITY SINGLE CODE MDR11_1 to CST95 Mappings

MTH_MAPTOEXHAUSTIVE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 MTH_MAPTOEXHAUSTIVE N MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 MTH_MAPTOEXHAUSTIVE N MDR11_1 to CST95 Mappings

TORSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 TORSAB ICD9CM MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 TORSAB CST MDR11_1 to CST95 Mappings

TOVSAB

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C2242749 A15837029 L8082422 S10132036 CODE MTHU000002 TOVSAB ICD9CM_1998 MDR11_1 to ICD9CM_1998 Mappings
C2242750 A15837158 L8082421 S10132035 CODE MTHU000001 TOVSAB CST95 MDR11_1 to CST95 Mappings

Last reviewed: 29 April 2009
Last updated: 29 April 2009
First published: 29 April 2009
Metadata| Permanence level: Permanence Not Guaranteed